The American Heart Association (AHA) worked on cardiovascular health, and in 2010 they defined a new construct about cardiovascular health in which they promote shifting the focus from disease treatment to healthy activities and...
Most Recent Articles
ARNI vs. ACEi In Reducing Heart Failure Events Post-Myocardial Infection: The PARADISE-MI Trial
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are drugs of renin angiotensin system (RAS) that are mostly used in heart failure following acute myocardial infarction(AMI). These RAS...
Improved Outcomes In Age-Irrespective Heart Failure and Preserved Ejection Fraction Patients From Empagliflozin Treatment
While it is known that empagliflozin plays a vital role in reducing cardiovascular death (CVD) or heart failure (HF) hospitalization (HFH) in HF and preserved ejection fraction patients, its treatment effects and age-related...
Links Found Between COVID-19 Post-Recovery and Incident Heart Failure
To investigate the related events surrounding COVID-19 post-recovery and the development of de novo heart failure, the post-recovery outcomes of 587,330 patients from the United States were examined. The data was obtained from...
VISUALIZED: Early Rhythm Control Therapy Effects With Atrial Fibrillation
Read further: Early Rhythm Control Therapy Effects With Atrial Fibrillation